2. Nafidine derivatives, Syk quinasa inhibitors； intermediate compounds, including their pharmaceutical synthesis； and compounds for the treatment of allergic nephritis, asthma, EPOC, lupus erythematosus, urticaria/angioplasty and other diseases.
HOFFMANN MATTHIAS,DAHMANN GEORG,FIEGEN DENNIS,HANDSCHUH SANDRA,KLICIC JASNA,LINZ GUENTER,SCHAENZLE GERHARD,EAST STEPHEN P.,MAZANETZ MICHAEL PHILIP,SCOTT ROBERT JOHN,WALKER EDWARD,SCHNAPP ANDREAS
申请号：
CL2012001807
公开号：
CL2012001807A1
申请日:
2012.07.04
申请国别(地区):
CL
年份:
2012
代理人:
摘要：
Compounds derived from naftiridinas replacedAs inhibitors of Syk kinase intermediaries； Compounds； Pharmaceutical formulations that include； and its use for the treatment of selected diseases including allergic rhinitis, Asthma,COPD, systemic lupus erythematosus, urticaria / angioedema, among others.<；p>；Compuestos derivados de naftiridinas sustituidas, como inhibidores de la SYK quinasa； compuestos intermediarios； formulaciones farmacé；uticas que las comprenden； y su uso para el tratamiento de enfermedades seleccionadas entre rinitis alé；rgica, asma, epoc, lupus eritematoso, urticaria/angioedema, entre otras.<；/p>；
